Methadone Treatment Centers in Nevada

Adults with a clinical diagnosis of opioid use disorder (OUD) are eligible for methadone treatment in Nevada. A licensed clinician confirms the diagnosis during intake using DSM-5 criteria, and the provider verifies identity and medical history before the first dose or injection.

Most Nevada programs include routine urine drug screens in the program fee. Baseline lab work (liver function, pregnancy test, ECG for methadone) may be billed separately — $30–$150 depending on insurance status. Ask about lab fees at intake.

Yes. Nevada Medicaid covers the mandated counseling component for MAT — individual therapy, group sessions, and care coordination — at participating Nevada clinics. Reimbursement for peer-support specialists is also available under the state plan.

Yes. Medicare Part B covers methadone through enrolled Opioid Treatment Programs and Part D covers buprenorphine and naltrexone prescriptions. Medicare Advantage plans in Nevada include the same MAT benefits under the integrated plan structure.

Yes. DEA rules were permanently expanded in 2024 to allow audio-video telehealth for initial buprenorphine prescribing, and Nevada law mirrors federal policy. Methadone induction still requires an in-person visit at an OTP for the first dose, though subsequent counseling can be delivered via telehealth. Naltrexone can be prescribed via telehealth with labs done in Nevada.

Methadone tapering generally takes longer than buprenorphine because of its long half-life and higher cumulative-dose equilibrium. Most Nevada clinicians taper methadone over 6–12 months or longer. Buprenorphine tapers often complete in 3–6 months for stable patients.

Call a methadone clinic directly, SAMHSA’s national helpline (1-800-662-4357), or 988 for urgent help. Most Nevada methadone clinics offer same-day or next-business-day intake; the intake visit includes an assessment and your first dose or prescription.

Sometimes. Comfort medications for withdrawal (clonidine, ondansetron, loperamide) may be prescribed alongside methadone at your first visit. Nevada clinicians will also address any mental-health medications, pain control, or chronic-disease meds that need coordination.

Combining alcohol with methadone or buprenorphine increases sedation and respiratory-depression risk; avoidance is strongly recommended. Naltrexone treats alcohol use disorder directly and is not impaired by occasional drinking, but heavy drinking can still cause liver harm. Be honest about use with your Nevada clinician.

Yes. Methadone and buprenorphine are the evidence-based standard of care in pregnancy, endorsed by ACOG and SAMHSA. Staying on MAT protects both mother and fetus; unmedicated withdrawal is riskier than continued MAT. Nevada providers coordinate care with obstetrics.

No — counselors with master’s-level licensure (LCSW, LPC, LMFT) provide therapy but do not prescribe medication. A nurse practitioner, physician assistant, or physician on the Nevada MAT team handles the prescription. Counselor and prescriber collaborate on your care plan.

Yes, with proper documentation. Bring a letter from your Nevada MAT prescriber, medication in its original pharmacy container, and check destination-country rules — some countries restrict methadone and buprenorphine. The International Narcotics Control Board maintains destination-country guidance.